Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015

No abstract is available for this paper.

• Publication year

  2016

• Venue

  HIV Clinical Trials

• Publication date

  2016-07-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/15284336.2016.1212561PMID 27465646PMCID PMC5002236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA).

  2016cited by this paper
• Tenofovir-based preexposure prophylaxis for HIV infection among African women.

  2015cited by this paper
• HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure Prophylaxis Trial

  2015cited by this paper
• Linkage to care following a home-based HIV counselling and testing intervention in rural South Africa

  2015cited by this paper
• Behavior Change and Other Factors Related to HIV Transmission among Female Sero-converters in Microbicide Trials

  2015cited by this paper
• Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women

  2015cited by this paper
• Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention

  2015cited by this paper
• Linkage to HIV care, postpartum depression, and HIV-related stigma in newly diagnosed pregnant women living with HIV in Kenya: a longitudinal observational study

  2014cited by this paper
• Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial.

  2014cited by this paper
• HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

  2014cited by this paper
• Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies

  2013cited by this paper
• Effect of Computer-Assisted Interviewing on Self-Reported Sexual Behavior Data in a Microbicide Clinical Trial

  2013cited by this paper
• Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

  2012cited by this paper
• Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

  2012cited by this paper
• Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.

  2012cited by this paper
• Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

  2012cited by this paper
• Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

  2011cited by this paper
• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

  2010cited by this paper
• Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

  2010cited by this paper
• Depressive Symptoms Increase Risk of HIV Disease Progression and Mortality Among Women in Tanzania

  2007cited by this paper
• Validity of the Hopkins Symptom Checklist‐25 amongst HIV‐positive pregnant women in Tanzania

  2002cited by this paper
• Psychiatric illness in family practice.

  1980cited by this paper

• Risk Compensation in the Context of Sexually Transmitted Infections in Women Using the Dapivirine Vaginal Ring in Africa: A Scoping Review

  2025influential citation
• Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa: A Prospective Cohort Study

  2022cites this paper
• Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.

  2022cites this paper
• Likely clinical depression and HIV-related decline in antiretroviral therapy untreated women who seroconverted during participation in microbicide trials in sub-Saharan Africa

  2021cites this paper
• Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence.

  2019cites this paper
• Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial

  2019cites this paper
• Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring.

  2018cites this paper
• Kinase Inhibitors and Nucleoside Analogues as Novel Therapies to Inhibit HIV-1 or ZEBOV Replication

  2017cites this paper
• HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial

  2017cites this paper